A blood-based metabolomics test to distinguish relapsing-remitting and secondary progressive multiple sclerosis: addressing practical considerations for clinical application (2020)
Attributed to:
MRC Centre for Neuropsychiatric Genetics and Genomics
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-020-69119-3
PubMed Identifier: 32709911
Publication URI: http://europepmc.org/abstract/MED/32709911
Type: Journal Article/Review
Parent Publication: Scientific Reports
Issue: 1
ISSN: 2045-2322